Briefing
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission
Postinduction molecular MRD in NPM1-mutated AML used to identify patients who benefit from allogeneic transplant in first complete remission. Level 2.
- Design: paper
- Assay: Postinduction molecular NPM1 MRD